Le dispositif de traitement des insuffisances cardiaques Occlutech AFR obtient le marquage CE

By In The News
September 6, 2019 in The Headlines

Recommended Posts

In The News

Posted September 6, 2019

- Share

Posted September 6, 2019

SCHAFFHOUSE, Suisse, 6 septembre 2019 /PRNewswire/ -- Occlutech AG a annoncé aujourd'hui que son régulateur de débit auriculaire, le dispositif Occlutech AFR, avait obtenu le marquage CE lui permettant de commercialiser ce produit sur le marché réglementé européen. Occlutech AFR est un...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  219815
2. Jaydee
  16697
3. Kip Powick
  12207
4. deicer
  12185
5. dagger
  9595
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.1k
- Total Posts
  
  558.5k

Sign In

Le dispositif de traitement des insuffisances cardiaques Occlutech AFR obtient le marquage CE

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support